Association of serum 25-hydroxyvitamin D concentrations with sleep phenotypes in a German community sample.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 29 01 2019
accepted: 20 06 2019
entrez: 6 7 2019
pubmed: 6 7 2019
medline: 4 3 2020
Statut: epublish

Résumé

Sleep disorders and vitamin D deficiency are among the most common health problems. Few studies investigated the effect of vitamin D on objectively recorded sleep with sound methodological quality and reasonable temporal proximity. To investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) concentrations and objective sleep parameters assessed within close temporal proximity in a population-based sample. It is expected that higher serum 25(OH)D concentrations are associated with 1) better objective sleep outcomes (longer sleep duration, higher sleep efficiency, earlier mid-sleep time) and 2) more positive subjective sleep evaluations. A subset of participants (n = 1045) from the LIFE-Adult-Study was analysed. Measurement of serum 25(OH)D vitamin was performed using an electrochemiluminescence immunoassay. Actigraphic assessments were performed using SenseWear Pro 3 devices. The following objective sleep parameters were calculated: total sleep duration, night sleep duration, night sleep efficiency, midsleep time and wake after sleep onset (WASO). Subjective sleep evaluations were assessed via questionnaire (sleep quality (PSQI), daytime sleepiness (ESS)). Data were analysed applying a multiple linear regression model with a stepwise approach. The regression models revealed significant associations of serum 25(OH)D concentration with night sleep duration and midsleep time. No association was found for total sleep duration and night sleep efficiency. Higher serum 25(OH)D concentration was further associated with shorter WASO in males but longer WASO in females. Moreover, serum 25(OH)D concentration did not show any significant association with subjective sleep quality and daytime sleepiness. The results indicate that a higher concentration of serum 25(OH)D is associated with longer and earlier night sleep. Although the present study was able to demonstrate an association between serum 25(OH)D concentration and objective sleep parameters, no conclusion about underlying mechanisms or causal inferences can be drawn.

Sections du résumé

BACKGROUND
Sleep disorders and vitamin D deficiency are among the most common health problems. Few studies investigated the effect of vitamin D on objectively recorded sleep with sound methodological quality and reasonable temporal proximity.
OBJECTIVE
To investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) concentrations and objective sleep parameters assessed within close temporal proximity in a population-based sample. It is expected that higher serum 25(OH)D concentrations are associated with 1) better objective sleep outcomes (longer sleep duration, higher sleep efficiency, earlier mid-sleep time) and 2) more positive subjective sleep evaluations.
METHODS
A subset of participants (n = 1045) from the LIFE-Adult-Study was analysed. Measurement of serum 25(OH)D vitamin was performed using an electrochemiluminescence immunoassay. Actigraphic assessments were performed using SenseWear Pro 3 devices. The following objective sleep parameters were calculated: total sleep duration, night sleep duration, night sleep efficiency, midsleep time and wake after sleep onset (WASO). Subjective sleep evaluations were assessed via questionnaire (sleep quality (PSQI), daytime sleepiness (ESS)). Data were analysed applying a multiple linear regression model with a stepwise approach.
RESULTS
The regression models revealed significant associations of serum 25(OH)D concentration with night sleep duration and midsleep time. No association was found for total sleep duration and night sleep efficiency. Higher serum 25(OH)D concentration was further associated with shorter WASO in males but longer WASO in females. Moreover, serum 25(OH)D concentration did not show any significant association with subjective sleep quality and daytime sleepiness.
CONCLUSION
The results indicate that a higher concentration of serum 25(OH)D is associated with longer and earlier night sleep. Although the present study was able to demonstrate an association between serum 25(OH)D concentration and objective sleep parameters, no conclusion about underlying mechanisms or causal inferences can be drawn.

Identifiants

pubmed: 31276483
doi: 10.1371/journal.pone.0219318
pii: PONE-D-19-02755
pmc: PMC6611612
doi:

Substances chimiques

Biomarkers 0
Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0219318

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Sleep. 2015 Feb 01;38(2):251-7
pubmed: 25581929
Clin J Pain. 2013 Apr;29(4):341-7
pubmed: 22699141
Clin Chem. 2004 Aug;50(8):1415-7
pubmed: 15277348
PLoS One. 2014 Aug 19;9(8):e103490
pubmed: 25137304
Sleep Med Rev. 2014 Aug;18(4):311-9
pubmed: 24075129
Nutrients. 2018 Oct 01;10(10):
pubmed: 30275418
Med Hypotheses. 2012 Aug;79(2):132-5
pubmed: 22583560
J Nutr Sci. 2015 Nov 20;4:e37
pubmed: 26688723
Sleep Med. 2012 Apr;13(4):419-24
pubmed: 22317945
J Clin Sleep Med. 2012 Dec 15;8(6):693-7
pubmed: 23243403
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Chem Neuroanat. 2005 Jan;29(1):21-30
pubmed: 15589699
Dis Markers. 2015;2015:580474
pubmed: 26576069
Prev Med. 2016 Dec;93:166-170
pubmed: 27687537
Ann N Y Acad Sci. 2008;1129:287-304
pubmed: 18591489
FASEB J. 2015 Sep;29(9):4023-35
pubmed: 26071405
Asia Pac J Clin Nutr. 2016;25(2):333-9
pubmed: 27222417
J Sleep Res. 2016 Dec;25(6):690-701
pubmed: 27126917
Am J Clin Nutr. 2008 Aug;88(2):511S-512S
pubmed: 18689392
J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):611-4
pubmed: 15225848
Sleep Med. 2010 Feb;11(2):180-4
pubmed: 20005774
Eat Weight Disord. 2017 Mar;22(1):27-41
pubmed: 27553017
Int J Cardiol. 2013 Oct 12;168(5):5074-5
pubmed: 23938219
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):631-6
pubmed: 23703479
PLoS One. 2014 Apr 24;9(4):e95824
pubmed: 24763506
BMC Public Health. 2015 Jul 22;15:691
pubmed: 26197779
Sleep. 2011 Jul 01;34(7):859-67
pubmed: 21731135
Front Neuroendocrinol. 2013 Jan;34(1):47-64
pubmed: 22796576
Ann Thorac Med. 2013 Jan;8(1):53-7
pubmed: 23440703
J Am Geriatr Soc. 2014 Dec;62(12):2327-32
pubmed: 25516029
Neurosci Res. 2017 May;118:74-81
pubmed: 28526553
Mol Psychiatry. 2014 Apr;19(4):444-51
pubmed: 23568194
Mol Cell Endocrinol. 2017 Sep 15;453:131-143
pubmed: 28579120
Sleep Breath. 2013 Mar;17(1):139-46
pubmed: 22318784
Sleep Sci. 2015 Jan-Mar;8(1):9-15
pubmed: 26483937
Sleep Med. 2019 Feb;54:262-265
pubmed: 30660070
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jan;56(1):131-43
pubmed: 23275948
J Clin Endocrinol Metab. 2007 Jun;92(6):2058-65
pubmed: 17341569
Physiol Rev. 2016 Jan;96(1):365-408
pubmed: 26681795
Ann Occup Environ Med. 2017 Jun 24;29:25
pubmed: 28652922
Sleep. 2015 Aug 01;38(8):1305-11
pubmed: 25669179
PLoS One. 2011;6(5):e20433
pubmed: 21633708
J Epidemiol Community Health. 1995 Dec;49(6):645-6
pubmed: 8596103
PLoS One. 2017 Jul 7;12(7):e0180901
pubmed: 28686746
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Sleep. 2015 Feb 01;38(2):171-2
pubmed: 25581928
Sleep Med. 2017 Feb;30:229-239
pubmed: 28215254
Am J Clin Nutr. 2016 Apr;103(4):1033-44
pubmed: 26864360
J Clin Hypertens (Greenwich). 2011 Oct;13(10):739-43
pubmed: 21974761

Auteurs

Ezgi Dogan-Sander (E)

Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Leipzig, Germany.

Anja Willenberg (A)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany.
LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

İnci Batmaz (İ)

Department of Statistics, Arts and Sciences Faculty, Middle East Technical Faculty, Ankara, Turkey.

Cornelia Enzenbach (C)

LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Institute for Medical Informatics, Statistics, and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.

Kerstin Wirkner (K)

LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Elisabeth Kohls (E)

Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Leipzig, Germany.

Roland Mergl (R)

LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Institute of Clinical Psychology and Psychotherapy, Bundeswehr University Munich, Neubiberg, Germany.

Joachim Thiery (J)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany.
LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Jürgen Kratzsch (J)

Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany.
LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Ulrich Hegerl (U)

Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Leipzig, Germany.
LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Christian Sander (C)

Department of Psychiatry and Psychotherapy, University of Leipzig Medical Center, Leipzig, Germany.
LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH